GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered
in Brentford, ... 6.1 Antitrust case over griseofulvin; 6.2 Ribena; 6.3 SB Pharmco
Puerto Rico; 6.4 China; 6.5 Market mani...
Issue: (1) Whether a third-party payor (TPP) states a plausible RICO injury by
alleging that a manufacturer's failure to disclose risk information inflated the price
Oct 22, 2013 ... Allied Services Division Welfare Fund v. GSK. : 09-CV-730 ... Plaintiffs bring
these actions against Defendant GlaxoSmithKline LLC (“GSK”) alleging. RICO
violations, violations of state consumer protection laws, and unjust ...
Apr 27, 2016 ... GlaxoSmithKline LLC v. ... WLF argued that the TPPs cannot satisfy RICO's
proximate-cause requirement because they lack a direct ...
Jul 22, 2013 ... MYLAN INC.; MYLAN PHARMACEUTICALS INC.,. Appellants v. SMITHKLINE
BEECHAM CORPORATION, n/k/a. GLAXOSMITHKLINE LLC, d/b/a
GLAXOSMITHKLINE;. SMITHKLINE ... Pharmco Puerto Rico, Inc. 2. GSK ...
Oct 6, 2014 ... New England Carpenters Health and Welfare Fund v. Abbott Laboratories, No. ....
Health and Welfare Fund v. GlaxoSmithKline LLC., No.
Jul 2, 2012 ... Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and
to pay $3 billion to resolve its criminal and civil liability arising ...
Jun 26, 2013 ... Federal District Court Strikes Blow Against RICO Challenges to Drug Co-pay
Coupons .... See Plumbers & Pipefitters Local 572 Health & Welfare Fund v. ...
Meanwhile, Defendant GlaxoSmithKline LLC. has requested that a ...
www.mondaq.com/unitedstates/x/438988/Class Actions/The Third Circuit Gives the Green Light to RICO Plaintiffs Seeking to Recover Payments for Prescription Drugs
Oct 28, 2015 ... ... the plaintiffs allege that GlaxoSmithKline LLC (GSK) engaged in a marketing
campaign to minimize ... The plaintiffs alleged claims under § 1964(c) of RICO. ...
Specifically, GSK relied on the Third Circuit's decision in Maio v.
Nov 5, 2014 ... On June 30, 2014, the court dismissed the RICO claims, joining a ... Council 37
Health & Security Plan et al. v. ... GlaxoSmithKline LLC., No.